Attention Investors: Lawsuit Filed Against Silvergate Capital Corporation – Contact Bragar Eagel & Squire, P.C. for More Info!

Welcome to the Silvergate Capital Corporation Class Action Lawsuit Alert! What’s Going On? So, you may have heard about the recent class action lawsuit filed against Silvergate Capital Corporation. If not, let me give you the lowdown. Bragar Eagel & Squire, P.C., a well-known stockholder rights law firm, has taken legal action against Silvergate in…

Read More

LM Funding America Inc. Chairman and CEO to Make Guest Appearance on Bloomberg Radio’s ‘Bloomberg Businessweek’ at 3:20 PM EST

Welcome to LM Funding America Blog! Breaking News: Chairman and CEO to Appear on Bloomberg Radio TAMPA, FL, Dec. 23, 2022 (GLOBE NEWSWIRE) – LM Funding America, Inc. (NASDAQ:LMFA) LM Funding America, Inc. (LMFA), a cryptocurrency mining and technology-based specialty finance company, is thrilled to announce that the Company’s Chairman and CEO, Bruce Rodgers, will…

Read More

Get Ready to Blast Off: RocketFuel Blockchain Predicts 1300% Surge in Crypto Transactions by 2022’s End!

Welcome to the Crypto Payment Revolution RocketFuel Blockchain Shattering Expectations San Francisco, CA, Dec. 23, 2022 (GLOBE NEWSWIRE) — RocketFuel Blockchain, Inc. (OTCQB: RKFL) (“RocketFuel” or the “Company”), a global provider of payment solutions via ACH bank transfers, Bitcoin and other cryptocurrencies, today announced that it is projecting an 1,300% increase in payment transactions processed…

Read More

Outlook Therapeutics Secures $31.8 Million in Unsecured Convertible Promissory Note: A Game-Changing Move in the World of Forex Trading

Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Notes Financing ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a leading biopharmaceutical company focused on developing and commercializing ophthalmic products for the treatment of retinal diseases, announced today that it has entered into a Securities Purchase Agreement (SPA)…

Read More

Breaking News: Connexa Sports Technologies Inc. Receives Notice from NASDAQ for Late Filing of Quarterly Report

Connexa Sports Technologies Inc. Faces Compliance Issue with Nasdaq Baltimore, Dec. 23, 2022 (GLOBE NEWSWIRE) Connexa Sports Technologies Inc. (NASDAQ: CNXA) recently announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) on December 20, 2022, informing the Company that it is not in compliance with the periodic filing requirements for…

Read More

Breaking News: Intercept Reapplies for FDA Approval of Obeticholic Acid for Liver Fibrosis in NASH Patients

Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis NDA supported by robust NASH clinical development program Two positive interim analyses from the Phase 3 REGENERATE study NDA includes detailed safety analysis of 2,477 patients with nearly 1,000 patients on study drug for 4 years MORRISTOWN, N.J., Dec….

Read More